SCHEMBL23767702

SCHEMBL23767702

CC(C)C1=CCN(F)CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL840146 0.78 KDM4E (0.41) PTPN1
SCHEMBL863307 0.76 QDPR (0.41)
SCHEMBL14731952 0.74 PTPN1 (0.31) PTPN1
SCHEMBL6127983 0.71 KDM4E (0.38)
SCHEMBL24536004 0.71
SCHEMBL7603813 0.71
SCHEMBL22893348 0.70 SOS1 (0.35)
SCHEMBL6124874 0.69 NAMPT (0.38)
SCHEMBL841052 0.69 KDM4E (0.35)
SCHEMBL104852 0.68 QDPR (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022078380-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2022-04-21 WO disclosed
WO-2022078407-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2022-04-21 WO disclosed
WO-2021160127-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2021-08-19 WO disclosed